Lv11
32 积分 2025-05-20 加入
Chemokine-chemokine receptor networks in conventional type I dendritic cells: an opportunity to prime and boost anticancer immunity
1小时前
待确认
Impact of oncogenic pathways on evasion of antitumour immune responses
6天前
已完结
Intratumoral delivery of FLT3L with CXCR3/CCR5 ligands promotes XCR1+ cDC1 infiltration and activates anti-tumor immunity
8天前
已完结
The emerging role of dendritic cells in the tumor microenvironment: from antigen presentation to targeted immunotherapy
8天前
已完结
Treatment of NSCLC after chemoimmunotherapy — are we making headway?
8天前
已完结
Advances in molecular pathology and therapy of non-small cell lung cancer
8天前
已完结
The next generation of immunotherapies for lung cancers
8天前
已完结
Cross-priming in cancer immunology and immunotherapy
9天前
已完结
Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity
11天前
已完结
Mechanistic insights into Wnt–β-catenin pathway activation and signal transduction
16天前
已完结
皖公网安备34019202002308
